- Home
- HEPS vs IMTX Comparison
HEPS vs IMTX Comparison
Compare HEPS & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HEPS | IMTX |
|---|---|---|
| Founded | 2000 | N/A |
| Country | Turkey | Germany |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HEPS | IMTX |
|---|---|---|
| Price | $2.76 | $6.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $3.27 | ★ $16.40 |
| AVG Volume (30 Days) | 119.0K | ★ 1.1M |
| Earning Date | 11-05-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $34.24 | N/A |
| Revenue Next Year | $29.65 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $6.09 |
| 52 Week High | $3.30 | $12.41 |
Technical Indicators
Market Signals| Indicator | HEPS | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.88 | 42.06 |
| Support Level | $2.74 | $6.65 |
| Resistance Level | $2.80 | $7.95 |
| Average True Range (ATR) | 0.08 | 0.45 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 68.97 | 40.85 |
Price Performance
Historical ComparisonAbout HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. It's portfolio offers its retail customers a wide selection of merchandise including electronics and non-electronics (including books, sports, toys, kids and baby products, cosmetics, furniture, etc). The Group derives revenue from the sales of goods, marketplace revenues and other revenues.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.